These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8507348)

  • 21. Development of acute withdrawal during periodic administration of amphetamine in rats.
    White W; Feldon J; White IM
    Pharmacol Biochem Behav; 2004 Sep; 79(1):55-63. PubMed ID: 15388284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behavior of rats during one-year administration of fluphenazine and subsequent withdrawal period.
    Trzeciak HI; Herman ZS; Szkilnik R; Opiełka L; Laskawiec G; Kryk A; Kmicińska M; Stańda J; Obuchowicz E; Bień E
    Pol J Pharmacol Pharm; 1986; 38(1):9-20. PubMed ID: 3763488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of repeated exposure to toluene or amphetamine on locomotor activity in rats.
    Wiaderna D; Tomas T
    Int J Occup Med Environ Health; 2000; 13(4):317-24. PubMed ID: 11276845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of acute and chronic administration of 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline on the function of the nigrostriatal dopaminergic system in rats.
    Lorenc-Koci E; Antkiewicz-Michaluk L; Kamińska A; Lenda T; Zieba B; Wierońska J; Smiałowska M; Schulze G; Rommelspacher H
    Neuroscience; 2008 Oct; 156(4):973-86. PubMed ID: 18809471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naltrexone attenuates amphetamine-induced locomotor sensitization in the rat.
    Häggkvist J; Björkholm C; Steensland P; Lindholm S; Franck J; Schilström B
    Addict Biol; 2011 Jan; 16(1):20-9. PubMed ID: 20192948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine transporter, but not tyrosine hydroxylase, may be implicated in determining individual differences in behavioral sensitization to amphetamine.
    Dietz DM; Tapocik J; Gaval-Cruz M; Kabbaj M
    Physiol Behav; 2005 Oct; 86(3):347-55. PubMed ID: 16126238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preexposure to MDMA ("Ecstasy") delays acquisition but facilitates MDMA-induced reinstatement of amphetamine self-administration behavior in rats.
    Morley KC; Cornish JL; Li KM; McGregor IS
    Pharmacol Biochem Behav; 2004 Oct; 79(2):331-42. PubMed ID: 15501310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute quetiapine dose-dependently exacerbates anhedonia induced by withdrawal from escalating doses of d-amphetamine.
    Zhornitsky S; Potvin S; Stip E; Rompré PP
    Eur Neuropsychopharmacol; 2010 Oct; 20(10):695-703. PubMed ID: 20605419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic blockade of neurotensin receptors strongly reduces sensitized, but not acute, behavioral response to D-amphetamine.
    Panayi F; Dorso E; Lambás-Señas L; Renaud B; Scarna H; Bérod A
    Neuropsychopharmacology; 2002 Jan; 26(1):64-74. PubMed ID: 11751033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain transcription factor gene expression, neurotransmitter levels, and novelty response behaviors: alterations during rat amphetamine withdrawal and following chronic injection stress.
    Persico AM; Schindler CW; Zaczek R; Brannock MT; Uhl GR
    Synapse; 1995 Mar; 19(3):212-27. PubMed ID: 7784961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clozapine pre-treatment has a protracted hypolocomotor effect on the induction and expression of amphetamine sensitization.
    Herrera AS; Casanova JP; Gatica RI; Escobar F; Fuentealba JA
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():1-6. PubMed ID: 23954739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Striatal acetylcholine release correlates with behavioral sensitization in rats withdrawn from chronic amphetamine.
    Bickerdike MJ; Abercrombie ED
    J Pharmacol Exp Ther; 1997 Aug; 282(2):818-26. PubMed ID: 9262346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Withdrawal from repeated treatment with ethanol induces a protracted decrease in novelty-seeking behavior and enhancement of environmental habituation in mice.
    Fukushiro DF; Saito LP; Mári-Kawamoto E; Aramini TC; Costa JM; Josino FS; Uehara RA; Frussa-Filho R
    Pharmacol Biochem Behav; 2012 Mar; 101(1):132-7. PubMed ID: 22212452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual action on central dopamine function of transdihydrolisuride, a 9, 10-dihydrogenated analogue of the ergot dopamine agonist lisuride.
    Wachtel H; Dorow R
    Life Sci; 1983 Jan; 32(4):421-32. PubMed ID: 6827903
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of short-term abstinence from escalating doses of D-amphetamine on drug and sucrose-evoked dopamine efflux in the rat nucleus accumbens.
    Vacca G; Ahn S; Phillips AG
    Neuropsychopharmacology; 2007 Apr; 32(4):932-9. PubMed ID: 16885936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of chronic subcutaneous minipump infusion of lisuride upon locomotor activity of rats.
    Wachtel H; Rettig KJ; Löschmann PA
    J Neural Transm Suppl; 1988; 27():177-83. PubMed ID: 3165433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
    Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of tolerance to the suppressant effect of the neurotensin analogue NT69L on amphetamine-induced hyperactivity.
    Hertel P; Byskov L; Didriksen M; Arnt J
    Eur J Pharmacol; 2001 Jun; 422(1-3):77-81. PubMed ID: 11430916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of withdrawal from an escalating dose schedule of d-amphetamine on sexual behavior in the male rat.
    Barr AM; Fiorino DF; Phillips AG
    Pharmacol Biochem Behav; 1999 Nov; 64(3):597-604. PubMed ID: 10548277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioral assessment of high-dose amphetamine withdrawal: importance of training and testing conditions.
    Schindler CW; Persico AM; Uhl GR; Goldberg SR
    Pharmacol Biochem Behav; 1994 Sep; 49(1):41-6. PubMed ID: 7816888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.